Abstract: An apparatus and method for detecting refractive index variations in a sample is disclosed. The apparatus includes a multi frequency laser source configured to generate a mixed laser beam having at least two optical frequencies. A sinusoidal function generator is configured to modulate the optical frequencies to generate a chirp-modulated mixed laser beam. The chirp-modulated mixed laser beam being configured to pass through the sample. A detector is configured to detect the chirp-modulated mixed beam. A signal processer is configured to process the detected chirp-modulated mixed beam to measure refractive index variations in the sample.
Abstract: A photonic integrated circuit comprises a first waveguide with a first mode of light propagating therein and a second waveguide with a second mode of light propagating therein. The first and second modes of light have different effective indices of refraction. A taper formed in the second waveguide facilitates communication of light between waveguides. Each of the first and second waveguides operate to perform at least one of the generating light, detecting light, and transporting light.
Type:
Grant
Filed:
June 4, 2002
Date of Patent:
September 21, 2004
Assignee:
The Trustess of Princeton University
Inventors:
Stephen R. Forrest, Milind R. Gokhale, Fengnian Xia, Vinod Menon
Abstract: N-alkanoylglutamic acid derivatives in which the alkanoyl group is substituted with the 2-amino-4-hydroxy-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidine-6-yl or 2,4-diamino-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidin-6-yl group are antineoplastic agents. Typical embodiments are N-[6-(2-amino-4-hydroxy-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidin-6-yl)hexa noyl]-L-glutamic acid and N-[4-{-(2-amino-4-hydroxy-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidin-6-yl ethyl}cyclohex-1-yl]-L-glutamic acid.
Type:
Grant
Filed:
May 25, 1988
Date of Patent:
November 21, 1989
Assignees:
The Trustess of Princeton University, Eli Lilly and Company